- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07771842
Impact of a Targeted Nutritional Intervention on Glycaemic Variability and Correlation Between Glycaemic Parameters and Satiety. (APETIT)
Impact of a Targeted Nutritional Intervention on Glycaemic Variability
Obesity affects 18% of French adults and increasingly impacts adolescents. Dietary management is challenging, particularly with eating disorders like hyperphagia. The study hypothesizes that glycaemic variability contributes to eating disorders, as blood glucose fluctuations and reactive hypoglycaemia may exacerbate compulsive eating. Currently, no data exists on the relationship between glycaemic profile and satiety in obese adolescents.
This exploratory study will establish foundation for larger research evaluating glucose sensors as therapeutic education tools in obesity management, helping patients understand diet-satiety relationships.
Studieöversikt
Status
Betingelser
Studietyp
Inskrivning (Beräknad)
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
- Namn: Carine Villanueva, Dr
- Telefonnummer: 04 72 12 95 52
- E-post: carine.villanueva@chu-lyon.fr
Studera Kontakt Backup
- Namn: Emily Beaufils, Dr
- E-post: emily.beaufils@chu-lyon.fr
Studieorter
-
-
-
Bron, Frankrike, 69500
- Hôpital-Femme-Mère-Enfant - Service d'endocrinologie et diabétologie pédiatrique
-
Kontakt:
- Carine Villanueva, Dr
- Telefonnummer: 04.72.11.88.90
- E-post: carine.villanueva@chu-lyon.fr
-
Huvudutredare:
- Carine Villanueva, Dr
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Adolescents who have entered puberty (Tanner S2+ or G2+)
- Aged over 12 and under 18 years
- Obese, defined by an IOTF Body Mass Index (BMI) > 30
- Child's assent and consent from the person(s) exercising parental authority
Exclusion Criteria:
- Type 2 diabetes: HbA1c > 6.5% or fasting plasma glucose > 1.26 g/L
- Type 1 diabetes
- Treatment capable of altering the glycemic profile (e.g., corticosteroids)
- Intercurrent illness capable of significantly impacting eating behavior (e.g., Prader-Willi syndrome) or the postprandial glycemic profile
- Hypothalamic obesity
- Neuropsychomotor developmental disorders, intellectual disability
- History of bariatric surgery
- Pregnant, parturient, or breastfeeding women
- Persons deprived of liberty by a judicial or administrative decision
- Persons undergoing psychiatric care
- Persons admitted to a healthcare or social care facility for purposes other than the research
- Adults subject to a legal protection measure (guardianship, curatorship)
- Persons not affiliated with a social security scheme or beneficiaries of a similar scheme
- Participation in a study affecting appetite or blood glucose levels
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Förebyggande
- Tilldelning: N/A
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Adolescents in obesity
|
At Day 14, participants receive dietary counseling from a department dietician focusing on a low glycaemic index diet. The intervention includes:
Duration of intervention effect: 10 days (from Day 10 to Day 20) Monitoring: Participants maintain a food diary recording meal times and food types throughout the study period (Day 0 to Day 20). Continuous glucose monitoring is used to assess glycaemic response before (Day 0-10) and after (Day 10-20) the dietary intervention. Note: The placement of two CGM sensors serves as a Description: Placement of continuous glucose monitoring (CGM) sensors on the back of the participant's dominant arm. Two sensors are placed during the study:
Procedure: Sensors are placed according to manufacturer's recommendations. Participants receive general instructions on sensor maintenance and hygiene. Purpose: The sensors cross the skin barrier to continuously monitor glucose levels, providing data on:
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change in Rate of Glycaemic Change (ROC) at Pre- and Post-prandial Time Points
Tidsram: Day 0 to day 10 and Day 10 to day 20
|
Difference in the rate of change (ROC) in blood glucose levels (mg/dL/min) measured at each pre-prandial and post-prandial time point, comparing the baseline period (Day 0-10) to the post-intervention period (Day 10-20). ROC is calculated from continuous glucose monitoring data collected every 5 minutes. The change will be analyzed using paired statistical tests comparing mean ROC values before and after dietary intervention. |
Day 0 to day 10 and Day 10 to day 20
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change in Glycaemic Variability Parameters
Tidsram: Day 0 to Day 10 and Day 10 to Day 20
|
Change in glycemic variability and CGM-derived glucose metrics from baseline to post-intervention |
Day 0 to Day 10 and Day 10 to Day 20
|
|
Change in Satiety Scores
Tidsram: Day 20
|
Change in subjective satiety from baseline (before dietary intervention) to post-intervention, assessed using a Visual Analogue Scale (VAS; 0-100 mm) and the Satiety Labeled Intensity Magnitude (SLIM) Scale. |
Day 20
|
|
Correlation Between Glycaemic Parameters and Satiety Scores
Tidsram: Day 20
|
Correlation Between Glycaemic Parameters and Satiety Scores |
Day 20
|
Samarbetspartners och utredare
Sponsor
Studieavstämningsdatum
Studera stora datum
Studiestart (Beräknad)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
- Näringsstörningar
- Övernäring
- Kroppsvikt
- Övervikt
- Patologiska tillstånd, tecken och symtom
- Närings- och metabola sjukdomar
- Tecken och symtom
- Fetma
- Undersökningstekniker
- Kliniska laboratorietekniker
- Diagnostiska tekniker och procedurer
- Diagnos
- Blodkemisk analys
- Klinisk kemi -test
- Diagnostiska tekniker, endokrin
- Övervakning, fysiologisk
- Kontinuerlig glukosövervakning
Andra studie-ID-nummer
- 69HCL25_0864
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .